Gastrointestinal motility disorders (GMDs) are attributed to loss of interstitial cells of Cajal (ICC), whose survival and function are deeply dependent on the activation of KIT/SCF signalling. This evidence concerns the gene KIT and intrahepatic cholangiocarcinoma.